J. Infante

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Keith T. Flaherty, J. Infante, Adil Daud et al. · New England Journal of Medicine · 2012 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +16

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

Kyriakos P. Papadopoulos, Howard A. Burris, Michael S. Gordon et al. · Cancer Chemotherapy and Pharmacology · 2013 · 85 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors

Sharad Sharma, Vivek Abhyankar, R Burgess et al. · Annals of Oncology · 2009 · 56 citations · Full text

Medicine, Oncology, Pharmacology +9

Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist

Harvey Wong, Stephen E. Gould, Nageshwar Budha et al. · Drug Metabolism and Disposition · 2013 · 54 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma

Simon Chowdhury, J. Infante, Robert D. Hawkins et al. · Clinical Genitourinary Cancer · 2021 · 38 citations · Full text

Medicine, Oncology, Pharmacology +15